Latest News

Direxion Daily Regional Banks Bull 3x Shares (NYSEARCA:DPST) declared a quarterly dividend on Tuesday, March 19th, Wall Street Journal reports. Shareholders of record on Wednesday, March 20th will be paid a dividend of 0.149 per share on Tuesday, March 26th. This represents a $0.60 annualized dividend and a dividend yield of 1.25%. The ex-dividend date […]

Franklin Universal Trust (NYSE:FT) declared a monthly dividend on Tuesday, March 19th, Wall Street Journal reports. Investors of record on Friday, March 29th will be paid a dividend of 0.032 per share by the financial services provider on Monday, April 15th. This represents a $0.38 annualized dividend and a yield of 5.48%. The ex-dividend date […]

Medallion Resources Ltd. (CVE:MDL) Director Don Lay sold 2,000,000 shares of Medallion Resources stock in a transaction on Friday, March 15th. The shares were sold at an average price of C$0.09, for a total transaction of C$180,000.00. Following the completion of the sale, the director now owns 1,400,678 shares in the company, valued at C$126,061.02. […]

First Foundation Advisors decreased its position in shares of iShares Russell 2000 Value ETF (NYSEARCA:IWN) by 29.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,789 shares of the company’s stock after selling 2,387 shares during the quarter. First Foundation Advisors’ holdings in […]

First Foundation Advisors bought a new position in SPDR Portfolio Aggregate Bond ETF (NYSEARCA:SPAB) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 32,661 shares of the company’s stock, valued at approximately $910,000. Other hedge funds and other institutional investors also recently made changes […]

Needham & Company LLC reiterated their buy rating on shares of Synaptics (NASDAQ:SYNA) in a report published on Tuesday. Needham & Company LLC currently has a $45.00 price objective on the software maker’s stock, down from their previous price objective of $60.00. Several other equities research analysts have also commented on the stock. JPMorgan Chase […]

Cantor Fitzgerald reissued their buy rating on shares of Exela Technologies (NASDAQ:XELA) in a research note released on Tuesday morning. They currently have a $9.00 target price on the stock. “. We maintain our Overweight rating and our 12-month PT of $9 on Exela. Quarterly top-line results were mostly in line with expectations, and 2019 […]

HSBC restated their hold rating on shares of Deutsche Bank (NYSE:DB) in a research note released on Tuesday morning. A number of other research firms also recently issued reports on DB. Barclays set a $8.00 target price on shares of Deutsche Bank and gave the company a sell rating in a report on Tuesday, November […]

Zacks Investment Research lowered shares of HUTCHISON CHINA/S (NASDAQ:HCM) from a hold rating to a sell rating in a research report report published on Tuesday morning. According to Zacks, “Hutchison China MediTech Limited researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China […]

SVB Financial Group (NASDAQ:SIVB) was the recipient of some unusual options trading on Tuesday. Traders bought 749 call options on the stock. This is an increase of approximately 761% compared to the typical daily volume of 87 call options. Several brokerages have recently weighed in on SIVB. Bank of America set a $280.00 target price […]

VoteCoin (CURRENCY:VOT) traded up 0.7% against the U.S. dollar during the 1 day period ending at 8:00 AM ET on March 20th. Over the last week, VoteCoin has traded up 9.6% against the U.S. dollar. VoteCoin has a total market capitalization of $43,495.00 and approximately $32.00 worth of VoteCoin was traded on exchanges in the […]

Zacks Investment Research cut shares of Citigroup (NYSE:C) from a buy rating to a hold rating in a report published on Tuesday morning. According to Zacks, “Shares of Citigroup have outperformed the industry in the past three months. Further, the company possesses an impressive earnings surprise history, beating the Zacks Consensus Estimate in all the […]

Gamida Cell (NASDAQ: GMDA) is one of 114 public companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its competitors? We will compare Gamida Cell to related companies based on the strength of its valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership. Institutional & Insider Ownership […]